Skip to main content

Advertisement

Log in

The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

CCR2 has been widely considered as a potential therapeutic target for autoimmune disease, particularly rheumatoid arthritis, and various CCR2 blocking agents have been developed, some of which have entered clinical trials. In this review, we examine the relevant information regarding the role of CCR2, and to a lesser extent of the closely related chemokine receptor CCR5, in the immunopathogenesis of collagen-induced arthritis, an animal model of rheumatoid arthritis. Experimental evidence showing that CIA is accelerated and exacerbated when CCR2 is genetically inactivated (knockout mice) or blocked with specific antibodies warrant additional investigations before the relevance of the findings in rodent models can be applied to human patients with RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94:12053–12058

    Google Scholar 

  2. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552–2561

    Google Scholar 

  3. Staines NA, Wooley PH (1994) Collagen arthritis–what can it teach us? Br J Rheumatol 33:798–807

    Google Scholar 

  4. Goldring SR (2003) Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42:11–16

    Google Scholar 

  5. Stuart JM, Watson WC, Kang AH (1988) Collagen autoimmunity and arthritis. FASEB J 2:2950–2956

    Google Scholar 

  6. Brand DD, Kang AH, Rosloniec EF (2003) Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 25:3–18

    Article  PubMed  Google Scholar 

  7. Plows D, Kontogeorgos G, Kollias G (1999) Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J Immunol 162:1018–1023

    Google Scholar 

  8. Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 15:15–21

    Article  CAS  PubMed  Google Scholar 

  9. Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N (2001) Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 167:5381–5385

    Google Scholar 

  10. Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE (2001) Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 44:1022–1032

    Google Scholar 

  11. Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M (2001) Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol 126:551–559

    Google Scholar 

  12. Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V, Plachy J, Stangassinger M, Uhlig K, Schattenkirchner M, Schlondorff D (1999) Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 42:981–988

    Google Scholar 

  13. Villiger PM, Terkeltaub R, Lotz M (1992) Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 90:488–496

    Google Scholar 

  14. Pulsatelli L, Dolzani P, Piacentini A, Silvestri T, Ruggeri R, Gualtieri G, Meliconi R, Facchini A (1999) Chemokine production by human chondrocytes. J Rheumatol 26:1992–2001

    CAS  PubMed  Google Scholar 

  15. Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A (2000) Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 43:1734–1741

    Google Scholar 

  16. Patel DD, Zachariah JP, Whichard LP (2001) CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 98:39–45

    Google Scholar 

  17. Hayashida K, Nanki T, Girschick H, Yavuz S, Ochi T, Lipsky PE (2001) Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res 3:118–126

    Google Scholar 

  18. De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A (1999) Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol 26:425–431

    Google Scholar 

  19. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN (1995) Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 101:398–407

    Google Scholar 

  20. Thornton S, Duwel LE, Boivin GP, Ma Y, Hirsch R (1999) Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum 42:1109–1118

    Google Scholar 

  21. Gong JH, Yan R, Waterfield JD, Clark-Lewis I (2004) Post-onset inhibition of murine arthritis using combined chemokine antagonist therapy. Rheumatology (Oxford) 43:39–42

    Google Scholar 

  22. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN (1997) Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 57:117–120

    Google Scholar 

  23. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186:131–137

    Article  CAS  PubMed  Google Scholar 

  24. Barnes DA, Tse J, Kaufhold M, Owen M, Hesselgesser J, Strieter R, Horuk R, Perez HD (1998) Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 101:2910–2919

    Google Scholar 

  25. Youssef S, Maor G, Wildbaum G, Grabie N, Gour-Lavie A, Karin N (2000) C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J Clin Invest 106:361–371

    Google Scholar 

  26. Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V (2000) CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 1:288–289

    Google Scholar 

  27. Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S, Volck B, Svejgaard A, Andersen V (1998) CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 25:1462–1465

    Google Scholar 

  28. John S, Smith S, Morrison JF, Symmons D, Worthington J, Silman A, Barton A (2003) Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis. Arthritis Rheum 48:3615–3616

    Google Scholar 

  29. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB (2000) CCR2 expression determines Th1 vs Th2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 164:2021

    Google Scholar 

  30. Charo IF, Peters W (2003) Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization. Microcirculation 10:259–264

    Google Scholar 

  31. Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachy J, Bruhl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, Schlondorff D (2001) Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol 166:4697–4704

    Google Scholar 

  32. Maus U, von Grote K, Kuziel WA, Mack M, Miller EJ, Cihak J, Stangassinger M, Maus R, Schlondorff D, Seeger W, Lohmeyer J (2002) The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med 166:268–273

    Google Scholar 

  33. Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, Chenaux G, Reddick RL, Kuziel WA, Ahuja SS (2004) Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest 113:856–866

    Google Scholar 

  34. Bruhl H, Cihak J, Schneider MA, Plachy J, Rupp T, Wenzel I, Shakarami M, Milz S, Ellwart JW, Stangassinger M, Schlondorff D, Mack M (2004) Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J Immunol 172:890–898

    Google Scholar 

  35. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA (2000) The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol 68:144–150

    Google Scholar 

  36. Kuziel WA, Dawson TC, Quinones M, Garavito E, Chenaux G, Ahuja SS, Reddick RL, Maeda N (2003) CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 167:25–32

    Google Scholar 

  37. Moore BB, Paine R III, Christensen PJ, Moore TA, Sitterding S, Ngan R, Wilke CA, Kuziel WA, Toews GB (2001) Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 167:4368–4377

    Google Scholar 

  38. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL (2002) Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093–1103

    Google Scholar 

  39. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82

    Google Scholar 

  40. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59–70

    Google Scholar 

  41. Campbell IK, O’Donnell K, Lawlor KE, Wicks IP (2001) Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 107:1519–1527

    CAS  PubMed  Google Scholar 

  42. Flaishon L, Becker-Herman S, Hart G, Levo Y, Kuziel WA, Shachar I (2004) Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration. Blood 104:933–941

    Google Scholar 

  43. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS (2000) CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205–218

    Google Scholar 

  44. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112:1437–1443

    Google Scholar 

  45. Lim HW, Hillsamer P, Kim CH (2004) Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 114:1640–1649

    Google Scholar 

  46. Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozzani S, Girolomoni G, Cavani A (2001) Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166:996–1002

    CAS  PubMed  Google Scholar 

  47. Gaupp S, Pitt D, Kuziel WA, Cannella B, Raine CS (2003) Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains. Am J Pathol 162:139–150

    Google Scholar 

  48. Wipke BT, Allen PM (2001) Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 167:1601–1608

    Google Scholar 

  49. Nandakumar KS, Svensson L, Holmdahl R (2003) Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 163:1827–1837

    Google Scholar 

  50. Blease K, Mehrad B, Standiford TJ, Lukacs NW, Gosling J, Boring L, Charo IF, Kunkel SL, Hogaboam CM (2000) Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice. J Immunol 165:2603–2611

    Google Scholar 

  51. Kim Y, Sung S, Kuziel WA, Feldman S, Fu SM, Rose CE Jr (2001) Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). J Immunol 166:5183–5192

    Google Scholar 

  52. Spagnolo P, Renzoni EA, Wells AU, Sato H, Grutters JC, Sestini P, Abdallah A, Gramiccioni E, Ruven HJ, du Bois, RM, Welsh KI (2003) C-C chemokine receptor 2 and sarcoidosis: association with Lofgren’s syndrome. Am J Respir Crit Care Med 168:1162–1166

    Google Scholar 

  53. Ross SE, Williams RO, Mason LJ, Mauri C, Marinova-Mutafchieva L, Malfait AM, Maini RN, Feldmann M (1997) Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. J Immunol 159:6253–6259

    Google Scholar 

  54. Malfait AM, Williams RO, Malik AS, Maini RN, Feldmann M (2001) Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. Arthritis Rheum 44:1215–1224

    Google Scholar 

  55. Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN (2004) Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found Symp 256:53–69 (discussion 69-73, 106–111, 266–269)

    Article  PubMed  Google Scholar 

  56. Shanahan JC, St Clair W (2002) Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. Clin Immunol 103:231–242

    Google Scholar 

  57. Campbell IK, Hamilton JA, Wicks IP (2000) Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568–1575

    Google Scholar 

  58. Chu CQ, Song Z, Mayton L, Wu B, Wooley PH (2003) IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis 62:983–990

    Google Scholar 

  59. Ortmann RA, Shevach EM (2001) Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin Immunol 98:109–118

    Google Scholar 

  60. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746–754

    Google Scholar 

  61. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K (1999) Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 11:553–559

    Google Scholar 

  62. Santiago B, Galindo M, Rivero M, Brehmer MT, Mateo I, Pablos JL (2002) The chemoattraction of lymphocytes by rheumatoid arthritis—synovial fluid is not dependent on the chemokine receptor CCR5. Rheumatol Int 22:107–111

    Google Scholar 

  63. Yang YF, Mukai T, Gao P, Yamaguchi N, Ono S, Iwaki H, Obika S, Imanishi T, Tsujimura T, Hamaoka T, Fujiwara H (2002) A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur J Immunol 32:2124–2132

    Google Scholar 

  64. Gao P, Zhou XY, Yashiro-Ohtani Y, Yang YF, Sugimoto N, Ono S, Nakanishi T, Obika S, Imanishi T, Egawa T, Nagasawa T, Fujiwara H, Hamaoka T (2003) The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J Leukoc Biol 73:273–280

    Google Scholar 

  65. Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, McDermott DH, Murphy PM, Alkhatib G (2004) Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells. J Virol 78, 2277–2287

    Google Scholar 

  66. Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW, De Clercq E, Billiau A, Schols D (2001) AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 167:4686–4692

    Google Scholar 

  67. Mantovani A (1999) The chemokine system: redundancy for robust outputs. Immunol Today 20:254–257

    Google Scholar 

Download references

Acknowledgements

This work was supported in part by the National Institutes of Health (NIH) grants (AI48644) to S.S.A.; a South Texas Health Research Center, San Antonio Area Foundation and a Pfizer Scholar Award to M.P.Q.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Matthias Mack or Seema S. Ahuja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quinones, M.P., Estrada, C.A., Kalkonde, Y. et al. The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis. J Mol Med 83, 672–681 (2005). https://doi.org/10.1007/s00109-005-0637-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-005-0637-5

Keywords

Navigation